title: Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
authors.forename: V B
authors.initials: VB
authors.lastname: Djordjević
authors.forename: D
authors.initials: D
authors.lastname: Pavlović
authors.forename: M
authors.initials: M
authors.lastname: Pejović
authors.forename: N
authors.initials: N
authors.lastname: Lecić
authors.forename: D
authors.initials: D
authors.lastname: Koraćević
authors.forename: V
authors.initials: V
authors.lastname: Djordjević
authors.forename: V
authors.initials: V
authors.lastname: Stefanović
mesh_terms: D000740:Anemia / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D004912:Erythrocytes / Q000201:enzymology; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D000623:Porphobilinogen Synthase / Q000097:blood*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D000623:Porphobilinogen Synthase